| Previous Close | 84.31 |
| Open | 84.12 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 83.71 - 84.34 |
| 52 Week Range | 64.18 - 86.72 |
| Volume | 3,928,031 |
| Avg. Volume | 3,873,589 |
| Market Cap | 88.25B |
| Beta | 0.18 |
| PE Ratio (TTM) | 40.57 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.47%) |
| Ex-Dividend Date | 2017-05-11 |
| 1y Target Est | N/A |
- TheStreet.com•6 hours ago
On Not Talking About the 'Market'; Darth Vader, Meet Amazon: Jim Cramer's Best Blog
Jim Cramer discusses not discussing the 'market' and also suggests a Darth Vader-Amazon meeting.
- The Wall Street Journal•2 days ago
Health-Care Stocks Get a Boost From Senate Bill Rollout
Health care stocks got a lift Thursday after Senate Republicans rolled out their proposed bill to repeal Obamacare.
- Market Realist•4 days ago
Analyzing Eli Lilly’s Collaboration with KeyBioscience AG
On June 8, 2017, Eli Lilly (LLY) announced a strategic collaboration with KeyBioscience AG to focus on the development of dual amylin calcitonin receptor agonists (or DACRAs).